A prognostic survival model based on metabolism-related gene expression in plasma cell myeloma
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A prognostic survival model based on metabolism-related gene expression in plasma cell myeloma
Authors
Keywords
-
Journal
LEUKEMIA
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-03-08
DOI
10.1038/s41375-021-01206-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Crystal structures of human NSDHL and development of its novel inhibitor with the potential to suppress EGFR activity
- (2020) Dong-Gyun Kim et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Prognosis, Biology, and Targeting of TP53 Dysregulation in Multiple Myeloma
- (2020) Erin Flynt et al. Cells
- Next-Generation Sequencing for Clinical Management of Multiple Myeloma: Ready for Prime Time?
- (2020) Niccolo Bolli et al. Frontiers in Oncology
- Development and Validation of a 9-Gene Prognostic Signature in Patients With Multiple Myeloma
- (2019) Xiao-Ping Liu et al. Frontiers in Oncology
- Metabolic, anti-apoptotic and immune evasion strategies of primary human myeloma cells indicate adaptations to hypoxia
- (2019) Lukas Janker et al. MOLECULAR & CELLULAR PROTEOMICS
- Down‐regulated lncRNA SLC25A5‐AS1 facilitates cell growth and inhibits apoptosis via miR‐19a‐3p/PTEN/PI3K/AKT signalling pathway in gastric cancer
- (2019) Xiwen Li et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Epstein-Barr virus infection is associated with clinical characteristics and poor prognosis of multiple myeloma
- (2019) Bing Xia et al. BIOSCIENCE REPORTS
- Progress in the identification of gene mutations involved in multiple myeloma
- (2019) Ying Hu et al. OncoTargets and Therapy
- Hematopoietic score predicts outcomes in newly diagnosed multiple myeloma patients
- (2019) Abdullah S. Al Saleh et al. AMERICAN JOURNAL OF HEMATOLOGY
- Enhancing the R‐ISS classification of newly diagnosed multiple myeloma by quantifying circulating clonal plasma cells
- (2019) Wilson I. Gonsalves et al. AMERICAN JOURNAL OF HEMATOLOGY
- Metabolic Features of Multiple Myeloma
- (2018) et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- 18F-FDG PET/CT is useful for determining survival outcomes of patients with multiple myeloma classified as stage II and III with the Revised International Staging System
- (2018) Sung-Hoon Jung et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Metabolic Signature Identifies Novel Targets for Drug Resistance in Multiple Myeloma
- (2015) P. Maiso et al. CANCER RESEARCH
- Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group
- (2015) Antonio Palumbo et al. JOURNAL OF CLINICAL ONCOLOGY
- Cish actively silences TCR signaling in CD8 + T cells to maintain tumor tolerance
- (2015) Douglas C. Palmer et al. JOURNAL OF EXPERIMENTAL MEDICINE
- FR171456 is a specific inhibitor of mammalian NSDHL and yeast Erg26p
- (2015) Stephen B. Helliwell et al. Nature Communications
- Inhibition of ubiquitin conjugating enzyme UBE2C reduces proliferation and sensitizes breast cancer cells to radiation, doxorubicin, tamoxifen and letrozole
- (2013) Akhilesh Rawat et al. CELLULAR ONCOLOGY
- Targeting Fatty Acid Binding Protein (FABP) Anandamide Transporters – A Novel Strategy for Development of Anti-Inflammatory and Anti-Nociceptive Drugs
- (2012) William T. Berger et al. PLoS One
- FLNA, a new partner gene fused toMLLin a patient with acute myelomonoblastic leukaemia
- (2009) Etienne De Braekeleer et al. BRITISH JOURNAL OF HAEMATOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started